Studies in fibroblasts, neurons, and platelets have demonstrated the integration of signals from different G-protein coupled receptors (GPCRs) in raising intracellular free Ca
2+ . To study signal integration in macrophages, we screened RAW264.7 cells and bone marrow-derived macrophages (BMDM) for their Ca 2+ response to GPCR ligands. We found a synergistic response to complement component 5a (C5a) in combination with uridine 5'-diphosphate (UDP), platelet activating factor (PAF) or lysophosphatidic acid (LPA).
The C5a response was Gαi-dependent, while the UDP, PAF, and LPA responses were Gαq-dependent. Synergy between C5a and UDP, mediated by the C5a and P2Y6 receptors, required dual receptor occupancy, and affected the initial release of Ca 2+ from intracellular stores as well as sustained Ca 2+ levels.
C5a and UDP synergized in generating inositol-1,4,5-trisphosphate, suggesting synergy in activating phospholipase C (PLC) β. Macrophages expressed transcripts for three PLCβ isoforms (PLCβ2, PLCβ3, and PLCβ4), but GPCR ligands selectively used these isoforms in Ca 2+ signaling. C5a predominantly used PLCβ3, while UDP used PLCβ3 but also PLCβ4. Neither ligand required PLCβ2. Synergy between C5a and UDP likewise depended primarily on PLCβ3. Importantly, the Ca 2+ signaling deficiency observed in PLCβ3-deficient BMDM was reversed by reconstitution with PLCβ3. Neither PI-3 kinase nor PKC was required for synergy. In contrast to Ca 2+ , PI3-kinase activation by C5a was inhibited by UDP, as was macropinocytosis, which depends on PI3-kinase. PLCβ3 may thus provide a selective target for inhibiting Ca 2+ responses to mediators of inflammation, including C5a, UDP, PAF, and LPA.
Calcium is an important messenger involved in the regulation of multiple cellular processes, and levels of intracellular free calcium ([Ca 2+ ] i ) are precisely regulated (1) (2) (3) .
Increases in intracellular [Ca 2+ ] i are initiated by the phospholipase C (PLC) family of enzymes, which hydrolyze membrane-associated phosphatidylinositol-4,5-diphosphate (PIP 2 ) to produce inositol-1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DAG) (4) . IP 3 triggers the release of Ca 2+ from stores in the endoplasmic reticulum, while DAG activates members of the protein kinase C (PKC) family. Following activation of stored Ca 2+ by IP 3 , influx of extracellular Ca 2+ across the plasma membrane may further contribute to an increase in [Ca 2+ ] i , which is regulated by several Ca 2+ pumps and buffers (1) . The net level and duration of these Ca 2+ signals regulate cellular responses, including transcription, apoptosis, endocytosis, chemotaxis, and metabolism (3) .
Simultaneous stimulation of two GPCRs coupled to different Gα subunits, often Gαi or Gαs in combination with Gαq, has been shown to yield synergistic Ca 2+ responses in several model systems (reviewed in (5) ). Limited studies have demonstrated this synergy in primary cells, including neurons and platelets, but the mechanisms of synergy vary and are not well defined (6, 7) .
Synergistic Ca 2+ responses resulting from heterologous GPCR ligation have been little studied in macrophages, where members of the GPCR superfamily can stimulate an increase in [Ca 2+ ] i by activating members of the PLCβ family (4) . As part of a systematic screen of RAW264.7 macrophage cells, C5a and UDP demonstrated synergy in producing a rise in [Ca 2+ ] i (http://www.signaling-gateway.org/data/ cgi-bin/table2.cgi?cellabbr=RW) (8) ). C5a is an important inflammatory mediator for macrophages and UDP, which is released following cell damage, is also present at sites of from bones, erythrocytes were lysed, and the white cells were seeded in non-tissue culture Petri dishes for selection by growth and adhesion. After 6 days, over 99% of the surviving cells were macrophages, and these cells were maintained for up to 35 days in culture. Cells were cultured overnight in tissue culture (TC) plates prior to use in assays.
Lentivirus-mediated RNAi. Lentivirus was produced with a combination of three plasmids: (i) pCMV∆R8.91 packaging plasmid, (ii) pMD.G envelope plasmid (20, 21) , and (iii) a lentiviral vector plasmid (http://www.signalinggateway.org/data/plasmid). The packaging and envelope plasmids were generously provided by D. Trono, Geneva. The lentiviral vector plasmids contained shRNA sequences expressed under RNA polymerase III promoters (U6 or H1) upstream of a Ubi-C promoter driving bicistronic expression of either EGFP or an hCD4 marker, followed by a resistance gene for either puromycin or hygromycin (22) . Transfection of the 3 plasmids into 293T cells utilized lipofectamine 2000 (Invitrogen) and 20 µg of total DNA in a ratio of 4:3:2 for vector, packaging, and envelope plasmids respectively (PP00000200). Two days post-transfection, lentivirus was concentrated by using Centricon microfiltration tubes (PP00000202). Macrophages were infected at a multiplicity of infection of ~10 in the presence of polybrene at 4 µg/ml (PP00000215) (22) . shRNAs targeting murine PLCβ2 , PLCβ3 and PLCβ4 employed  the sequences GAA CAG AAG TTA CGT TGT  C, GCA GCG AGA TGA TTT GAT T, and  ACG CGA TTG AGT TTG TAA ATT A,  respectively. Retrovirus-mediated transduction of macrophages with PLCβ. pFB-neo vectors carrying YFP-tagged murine PLCβ3 or YFP-FLAG epitope were transfected into the PlatE packaging line (23) to produce ecotropic retroviruses for transduction of day-2 cultures of bone marrow cells, which were differentiated into BMDM as described above. PP00000181 ). Cells were stimulated under the same conditions used for the IP 3 assay. Then buffer was aspirated, the cells were scraped into Laemelli sample buffer, and the samples were heated. SDS-PAGE gels were loaded with 20 µg protein per lane, and Western blots were probed with anti-P-Akt, anti-P-ERK, and antiRho-GDI. Fluorescent signals, measured for PAkt and P-ERK by using a phosphoimager, were normalized to Rho-GDI.
Macropinocytosis assay. Macropinocytosis was assessed by measuring the cellular uptake of fluorescently labeled FITC-dextran. In brief, BMDM cells were cultured overnight in non-TC plates. Medium was replaced with Hank's Balanced Salt Solution with 1 mg/ml BSA, pH 7.4. After 1 hr ligands were added together with FITC-dextran (150 KDa MW, Sigma, 1 mg/ml final concentration in well). Activity was stopped with cold medium. After washing, cells were harvested in PBS with 5 mM EDTA and 5 mg/ml BSA, and analyzed by flow cytometry (FACSCalibur, BD) in 0.4% trypan blue solution (Sigma) to quench extracellular fluorescence. Ligand-stimulated activity was expressed as a ratio ('fold stimulation') to baseline activity.
Statistical Analyses. 
RESULTS

UDP and C5a interact to produce a synergistic calcium response in macrophages.
As part of a large-scale screen, we observed a synergistic interaction between UDP and C5a for Ca 2+ signaling (http://www.signalinggateway.org/data/cgi-bin/table2.cgi?cellabbr= RW). This response showed a faster rise time and an increased peak-offset (peak response minus baseline) compared to the predicted additive response by the individual ligands (Fig.  1A) . For the peak offset, the observed dualligand response was increased by 1.5 to 2-fold over the predicted additive response. Integration of the response over the first 20 sec yielded similar values. The ratio of observed/predicted values for such features of the response was referred to as the synergy ratio. BMDM showed a similar synergistic increase in the Ca 2+ response, but the synergy ratio was much greater than in RAW264.7 cells (Fig. 1B) .
For both cell types the optimal synergistic concentrations of each ligand were at or near the threshold for stimulation (Fig. 1C for BMDM, RAW264.7 data not shown). Synergy was nonetheless still observed at higher concentrations of both ligands, which fell within the linear portions of their dose-response curves. For RAW 264.7 cells, optimal concentrations for synergy were 0.25-100 nM C5a and 40-500 nM UDP, while for BMDM they were 0.1-3 nM C5a and 150-500 nM UDP.
Synergy is dependent on signaling through both Gαi-and Gαq-dependent GPCRs. C5a engages C5aR, which signals predominantly through Gαi-coupled heterotrimers (11, 25, 26) . Thus, in BMDM and in RAW264.7, the Ca 2+ response to C5a was inhibited following treatment with pertussis toxin (Ptx), whereas that of UDP was not ( Fig. 2A and supplemental Fig.  S1 ). Ptx-mediated inhibition of signaling by low concentrations of C5a (<1 nM) was complete, but at high concentrations residual Ptxinsensitive calcium signaling was detected both in WT BMDM and in BMDM from mice lacking either Gαq or Gα11 (data not shown). Saturation of Ptx-intoxication of the C5a Ca 2+ response was reached using 5 ng/ml for 18 hr, (supplemental Fig.  S1 ) Others have demonstrated a role for Gα15 in C5a signaling in primary macrophages (27) . While our data indicate that most C5a signaling is Ptx-sensitive, they are consistent with some signaling through Gα15 when C5a is present in high concentration. The Ca 2+ response to C5a in BMDM from mice genetically deficient in Gαi2 was intact (data not shown), suggesting that Gαi3 is sufficient to support C5a signaling in these cells, since Gαi1 and Go are not expressed in macrophages (data not shown). Inhibition by Ptx was similar to that observed for WT cells (data not shown).
UDP binds to purinergic receptors of the P2Y family, which usually signal through members of the Gαq family (12, 28, 29) . In accord with this, we found, that the Ca 2+ response was completely lost in BMDM from Gαq-deficient mice (Fig. 2B) . Surprisingly, although BMDM express other members of the Gαq family, including Gα11 and Gα15 (Fig.  2C ), these are evidently unable to substitute for Gαq in the response to UDP. Further, the BMDM from Gα11-deficient mice had no reduction in Ca 2+ responses for UDP (or for C5a, data not shown) compared with wildtype.
UDP only binds with high affinity to the P2Y6 receptor on macrophages. UTP, which has much lower affinity for P2Y6, binds also to P2Y2 and P2Y4 receptors (12, 28) .
To demonstrate that the responses to UDP did not involve contaminating UTP, we separately tested UTP and UDP before and after treatment with hexokinase (12) , which catalyzes conversion of UTP to UDP. Hexokinase treatment of UDP had no effect on its capacity to increase [ signaling. Little or no synergy was seen with UDP/PAF, UDP/LPA or PAF/LPA (data not shown). The levels of synergy observed for C5a paired with LPA or PAF ( Fig. 3A and B) were comparable to those for C5a paired with UDP.
PAF and LPA, like UDP, signaled Ca 2+ primarily through Gαq in BMDM ( Fig. 3C ), but unlike UDP this was not exclusive; in the Gαq-deficient cells residual Ca 2+ responses for PAF were abrogated by Ptx, indicating a minor contribution from Gαi-coupled pathways. Ptx did not reduce the Ca 2+ response to LPA, but instead surprisingly enhanced it in both Gαq-deficient and wt BMDM (Fig. 3D ). These data suggest for the first time that Gαi-coupled receptors basally inhibit LPA Ca 2+ signaling. As with UDP, synergy by either LPA or PAF with C5a was lost in Gαq-deficient BMDM (data not shown). Thus, although these receptors can activate some Ca 2+ signaling independently of Gαq, synergy with C5a nonetheless requires Gαq activation.
Overall, these results indicate that the simultaneous activation of Gαq and Gαi heterotrimers results in a synergistic Ca 2+ response in macrophages. C5aR was the only endogenous Gαi-coupled GPCR on BMDM that we found to be capable of generating a robust Ca 2+ response independently, and it was also the only receptor that synergized with ligands for Gαq-coupled receptors.
Synergy requires dual receptor occupancy. We next examined the possibility that one ligand might prime cells for subsequent responses, for example by increasing the supply of PIP 2 to provide a heightened state of responsiveness to the second stimulus (30) . Although synergy was greatest when C5a and UDP were added simultaneously, it was also evident when ligands were added as much as 10 min apart. The sequence of addition was irrelevant. Fig. 4A shows the results for ligands separated by 100 sec. However, removal of the first ligand during the interim eliminated synergy (Fig. 4B) (5) . In our studies, however, inhibition of PI3K by LY294002 or of PKC by Calphostin C or staurosporine did not significantly affect synergy (supplemental Fig. S2.) . The activity of the inhibitors was confirmed by inhibition of Akt or MARCKS phosphorylation (supplemental Fig.  S3 ) These data are further evidence that an early signaling event is involved in the mechanism of synergy.
C5a and UDP make selective use of PLCβ isoforms. To examine the role of PLCβ in the signaling response to C5a and UDP, we first determined levels of transcripts for PLCβ isoforms in RAW264.7 cells and in BMDMs. By both microarray analysis (data not shown) and by RT-PCR (Fig. 5) Fig. 6 ) and FcγRI signaling was normal. No loss of signaling to either UDP or C5a was seen in BMDM from mice deficient in PLCβ2. Thus, in BMDM, signaling by both C5a and UDP is selectively dependent on PLCβ3, but signaling by UDP is also partly dependent on PLCβ4.
To examine the role of PLCβ in RAW264.7 cells, we used RNAi against the different PLCβ isoforms.
The loss of PLCβ isoforms in response to RNAi was incomplete (supplemental Fig. S4 ), but this approach allowed the testing of a uniform cell line, and it avoided possible developmental effects on macrophages due to PLCβ isoform loss. The depletion of PLCβ3 from RAW264.7 cells by RNAi reduced signaling by C5a, though not to the same extent as in BMDM genetically deficient in PLCβ3 (Table 2 ). Cells depleted of PLCβ3 by RNAi were not deficient in their response to UDP, but RNAi against PLCβ4, caused a loss of signaling in response to UDP, with a slight elevation in C5a signaling (Table 2) (Fig. 6 B, C) Table 3) , as reflected by a reduced synergy ratio. Because signaling by individual ligands was lower than wildtype in these cells, the predicted additive responses were also lower, but a residual synergistic response was still detected in PLCβ3 deficient cells (Table 3) . Thus synergy in Ca 2+ signaling, like signaling by individual ligands, is primarily dependent on PLCβ3, but some synergy can be seen without it, Notably, lack of PLCβ4 did not reduce synergy in BMDM but instead enhanced it. We conclude that PLCβ3, but not PLCβ4, plays an important role in synergy between these ligands as well as in their individual responses.
As with Ca 2+ signaling, BMDM lacking PLCβ3, but not PLCβ4, failed to demonstrate synergy in the production of IP 3 (Fig. 7B) . Thus, studies of both Ca 2+ and IP 3 indicate that synergy in signaling by C5a and UDP is the result of enhanced activity of PLCβ3.
Dual-ligand effects on PI3-kinase contrast to those on PLC. In order to determine if the synergistic effects of C5a plus UDP dual ligand stimulation were reflected in signaling events other than PLC activation, we examined activation of PI3K. Gβγ subunits directly activate PI3K-p110γ (31) and GPCRs can also activate PI3K-p110α and PI3K-p110β (32) . The Gαq subunit does not activate PI3K, but instead can interact with and inhibit PI3K-p110α (33, 34) . Thus, PI3K activity reflects important proximal GPCR signals. To assess activation of PI3K, we measured the phosphorylation of Akt, which requires anchoring of its PH domain to PIP 3 produced by PI3K at the cell membrane. In BMDM, C5a rapidly activated PI3K, with peak phosphorylation of Akt at ~3 min (data not shown). In contrast, UDP did not activate PI3K, and it inhibited the phospho-Akt response to C5a (Fig. 8) . This inhibition of Akt phosphorylation by UDP was at least partially selective, as ERK phosphorylation showed additivity. UDP did not inhibit PI3K activation in response to the crosslinking of FcγRI (data not shown), demonstrating that signaling by UDP did not globally interfere with all forms of PI3K activation. The observation that UDP inhibits PI3K activation by C5a while promoting Ca 2+ signaling suggests that these pathways are differentially regulated.
The opposing effects of C5a/UDP signalinteractions on PLC and PI3K are reflected in macropinocytosis.
Macropinocytosis, the endocytic process whereby cells internalize substantial volumes of extracellular fluid and solutes, is dependent on both PLC and PI3K (35, 36) , and this 'sampling' of the environment contributes to macrophage antigen presentation (37, 38) .
We found that C5a activates macropinocytosis by BMDM, while UDP does not. Macropinocytosis was inhibited by dualligand stimulation (Fig. 9) , in contrast to synergy for PLC and Ca 2+ but in parallel with the inhibition of PI3K.
DISCUSSION
Our studies demonstrate the preferential use of PLCβ isoforms by GPCRs in eliciting a Ca 2+ response in macrophages. Further, they indicate that synergy in signaling by the Gαi-coupled C5aR, together with the Gαq-coupled P2Y6 receptor for UDP, depends on a selective use of PLCβ3. Synergy in the Ca 2+ response to C5a and UDP correlated with synergy in IP 3 production, suggesting signal convergence at the level of PLCβ activation. In contrast to Ca 2+ activation, synergy between C5a and UDP was not observed in PI3K activation. Instead, the activation of PI3K by C5a was opposed by UDP. A similar effect was seen in the activation of macropinocytosis, which is dependent on both PLC and PI3K. Thus, synergy was selective for IP 3 production and the Ca 2+ response, consistent with a selective effect on PLCβ.
The preferential use of PLC isoforms by GPCRs in macrophages did not simply reflect differential levels of expression of transcripts for the PLCβ isoforms. Four isoforms of PLCβ have been identified (4). We found that both BMDM and RAW264.7 cells expressed transcripts for PLCβ2, β3 and β4 but not PLCβ1, as determined by gene array analyses on Affymetrix chips and by RT-PCR. We have not been able to develop assays that adequately quantify differences in protein expression of these PLCβ isoforms, but our results nonetheless suggest that the selective use of PLCβ3 in macrophages for Ca 2+ signaling and synergy is despite the expression of PLCβ2 and PLCβ4. Thus, in contrast to platelets and neutrophils, PLCβ3 appears to be the major functional isoform in macrophages. While this paper was in preparation, Wang et al, also reported reduced Ca 2+ responsiveness to C5a by macrophages from PLCβ3-deficient mice, and they linked this to increased apoptosis, and diminished atherosclerosis (39) 2+ response, but responses may be facilitated in combination with, or after priming by, Gαq-coupled receptors (41) (42) (43) . This synergy is reflected in the generation of IP 3 , as in our current studies of macrophages, implicating PLC in the pathway of synergy.
Our findings narrow the possible mechanisms by which synergy in Ca 2+ signaling by macrophages may occur. All PLCβ isoforms can bind Gαq subunits, albeit with differing affinities (44) (45) (46) (47) (48) , and under certain conditions PLCβ4 demonstrates the highest specific activity for hydrolyzing PIP 2 (49) . Consistent with this, the absence of PLCβ4 reduced mobilization of [Ca 2+ ] i by all ligands that activate Gαq, including UDP, LPA, and PAF. The loss of PLCβ4, however, did not impair synergy but instead increased it. Thus, PLCβ4 appears to inhibit rather than promote synergy in macrophages. PLCβ2 and β3 are both potently activated by Gβγ (25,47,50,51), while PLCβ4 is not (49) . Although most Ca 2+ synergy was lost in mice lacking PLCβ3, we could still detect low levels of synergy. We hypothesize that PLCβ2 may be capable of mediating synergy, but in macrophages the contribution of PLCβ2 is small in relation to that of PLCβ3. At high ligand concentrations, C5a also demonstrated some Ptx-insensitive activation of Ca 2+ signaling. We found that this response was still present in Gαq-or Gα11-deficient mice, suggesting coupling of C5aR to the more promiscuous Gα15, as has been observed by others (27) . However, no Ca 2+ synergy was observed with the combination of two Gαq-family linked ligands. Optimal synergy was observed at low concentrations of C5a, where the C5a-stimulated Ca 2+ response was entirely Ptx sensitive, so we infer that the synergy is attributable to the Gαi activation by C5aR. In BMDM, the C5a receptor was the only Ca 2+ signaling receptor identified that was primarily dependent on Gαi.
GPCR-mediated PLCβ activation can be regulated by positive or negative feedback loops. The PH-domain of PLCβ preferentially binds to the phosphatidylinositiol-3-phosphate (PI3P) product of PI-3K (4) and thus PI3K has the potential to modulate PLCβ activity. In our studies, however, inhibition of PI3K by LY294002 did not alter the Ca 2+ synergy, indicating that PI3K does not measurably contribute to synergy. PKC may interact with PLC at several levels.
It can directly phosphorylate PLCβ, inactivating it (53). It can also phosphorylate and regulate signaling via GPCRs, and can phosphorylate some G proteincoupled receptor kinases (GRKs) (54). In our studies, however, inhibition of PKC with either Calphostin C or staurosporine did not alter Ca 2+ synergy.
The acute nature of the synergy observed (occurring within seconds of dual ligand addition) and the demonstrated requirement for simultaneous dual receptor occupancy argue against the possibility that one receptor might drive 'priming' events affecting responses to the second receptor.
Mechanisms for synergy reflecting priming effects have been proposed in a number of other systems (55). The immediate synergy in macrophages precludes changes in receptor or other protein expression levels. Alternatively, a priming event could increase the supply of the PLC substrate PIP 2 to enhance production of IP 3 (56-58), and in some cases this has been shown to persist for hours after first ligand stimulation. This synergy mechanism would not require dual receptor occupation during heterologous ligand stimulations of Ca 2+ unless increases in the supply of PIP 2 were lost rapidly (we tested 3 minutes after 1 st ligand removal by which time synergy was lost).
The consequences of combined signaling by C5a and UDP in macrophages may be particularly important in areas of inflammation, where C5a is produced, and where UDP may be released from dying cells (59). C5a in particular plays a central role in inflammation, and consequences of Ca 2+ signaling would be augmented by UDP, while consequences of PI3K activation would be inhibited. The recent report describing a reduction of atherosclerosis in PLCβ3-deficient mice, due to macrophage hypersensitivity to apoptotic induction, links inflammatory outcome to Ca 2+ signaling and survival in macrophages (39 Table 1 . Single-ligand Ca 2+ responses in PLCβ isotype-deficient BMDM. BMDMs derived from 4-7 individual PLCβ-deficient (-/-) mice per isoform were subjected to Ca 2+ assays for near maximal concentrations of several GPCR ligands: C5a (10 nM), UDP (2.5 µM), LPA (2.5 µM), and PAF (12.5 nM). Three to four assays per cell population & ligand were performed, with 3-4 replicate samples per assay. Responses were normalized to the matched WT BMDMs in each assay and the table reports the average response of each isotype -/-as a % of WT response. Values are shown for peak-offset and integration to 60 sec measurements of the Ca 2+ responses. PLCβ3-deficient BMDM showed reduced responsiveness to four GPCR ligands but not following ligation of FcγRI (FCG). PLCβ4-deficient BMDM showed a reduced Ca 2+ response phenotype for UDP only. * p<0.05, ** p<0.005. Table 2 . RNAi against PLCβ3 and PLCβ4 in RAW264.7 reduces Ca 2+ responses to C5a and UDP respectively. RNAi against PLCβ isoforms in RAW264.7 cells was performed by lentiviral-mediated RNAi using shRNA encoding constructs. Control lines lacking only shRNA were prepared and analyzed in parallel with each RNAi line. Ca 2+ assays were performed with C5a (30nM) and UDP (25 µM) and responses were quantified by peak offset and integration to 1 or 2.5 min after ligand addition. Values were normalized to responses of control lines in each assay, and results of replicate lines were pooled to present the average response as a percent of control. Results represent 2-5 lines per target with 3-4 assays per line and 3-4 samples per ligand per assay. * p<0.05, ** p<0.01. Table 3 . Ca 2+ response synergy in PLCβ isotype-deficient BMDMs. BMDMs derived from individual PLCβ isotype-deficient mice were subjected to Ca 2+ assays for synergy between C5a and UDP (0.75 nM + 500 nM). Peak-offset values from Ca 2+ responses by Fura-2 loaded cells were normalized to corresponding controls in each assay. Data were pooled to report average values as a percent of control (%WT) for the individual ligands and corresponding predicted additive responses. Synergy observed was reported as a percent of the calculated additive Ca 2+ response for each cell type. Data were from 6 or 4 independent lines for PLCβ3 or PLCβ4-deficient cells respectively, with 2-4 replicate assays per population and 3-4 samples per condition per assay. * p<0.05, ** p<0.005. Fig 1. UDP and C5a produce a synergistic Ca 2+ response in macrophages. Intracellular Ca 2+ levels were calculated for Fura-2-loaded adherent macrophage populations from kinetic assays in 96-well plates. After 40 sec baseline readings, ligands were added and responses were monitored for 2.5 min. Each line in the graphs represents the average of 3-4 individual wells per assay and the error bars (SEM) are shown for the dual-ligand line in each graph. Synergy was evaluated by comparing the experimentally observed dual ligand responses to the predicted additive responses of the individual ligands. The dual-ligand response was quantified as the ratio of the observed/predicted additive responses and the term 'synergy ratio' was applied to the ratio of the peak offsets (PO = peak height -baseline). A. RAW264.7 cells were stimulated with UDP (2.5 µM), C5a (10 nM) or simultaneous UDP and C5a . Synergy ratio = 1.38. This is a representative experiment of n=12 with similar results. B. BMDM were stimulated with UDP (500 nM), C5a (0.37 nM) or simultaneous UDP and C5a. Synergy ratio = 2.62. This is a representative experiment of >25 with similar results. C. Dose-response pattern for simultaneous UDP and C5a-stimulated Ca 2+ responses quantified by synergy ratio. Ligand concentrations are expressed as log(nM). The optimal synergy ratio was at ~ 300 nM UDP + 0.3 nM C5a. The surface was interpolated from 84 individual experiments composed of 15 samples each. Adherent BMDM were stimulated with C5a (10 nM), UDP (10 µM), LPA (2.5 µM), PAF (50 nM), C5a plus UDP, C5a plus LPA or C5a plus PAF. After 1 min of stimulation, the assay was stopped by sample lysis. Western blots were probed with specific antibodies and were quantified by using a phosphorimager. Phosphoprotein values were normalized to levels of RhoGDI in the samples and then expressed as a fold-increase above the baseline level, represented by the average of control cell samples not stimulated with specific ligands. Data are shown for P-Akt and P-ERK from nine replicate experiments as mean+/-SEM. * p<0.05, ** p<0.01. 
